Loading…

99mTc-MAG3, a new renal imaging agent: preliminary results in patients

99mTc-mercaptoacetyltriglycine (MAG3) is a new renal radiopharmaceutical which has been shown to have biological properties similar to 131I-hippurate (OIH) in animals and volunteers. 99mTc-MAG3 has now been compared with 131I-orthoiodohippurate (OIH) in a group of patients with varying degrees of re...

Full description

Saved in:

Bibliographic Details
Published in:	European Journal of Nuclear Medicine 1987, Vol.12 (10), p.510-514
Main Authors:	Taylor, Jr, A, Eshima, D, Alazraki, N
Format:	Article
Language:	English
Subjects:	Adult Female Humans Iodine Radioisotopes Iodohippuric Acid Kidney - diagnostic imaging Kidney - physiopathology Kidney Transplantation Oligopeptides Organometallic Compounds Radionuclide Imaging Technetium Tc 99m Mertiatide Ureteral Obstruction - diagnostic imaging
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c1296-5515d157988cd6e1445554f4c974278efc069b8c718f87fb9ac9ab564dc8b0b63
cites	cdi_FETCH-LOGICAL-c1296-5515d157988cd6e1445554f4c974278efc069b8c718f87fb9ac9ab564dc8b0b63
container_end_page	514
container_issue	10
container_start_page	510
container_title	European Journal of Nuclear Medicine
container_volume	12
creator	Taylor, Jr, A Eshima, D Alazraki, N
description	99mTc-mercaptoacetyltriglycine (MAG3) is a new renal radiopharmaceutical which has been shown to have biological properties similar to 131I-hippurate (OIH) in animals and volunteers. 99mTc-MAG3 has now been compared with 131I-orthoiodohippurate (OIH) in a group of patients with varying degrees of renal impairment. In all cases, the 99mTc-MAG3 images were superior regardless of serum creatinine. Selected examples are illustrated including scans and renogram curves in a normal volunteer, transplant patients with creatinines of 9.8 mg/dl and 2.6 mg/dl respectively, and a furosemide study in a patient with questionable obstruction. Our preliminary results suggest that 99mTc-MAG3 performs well in patients with impaired renal function and may well provide an acceptable replacement for OIH. A kit formulation has been developed and will soon be undergoing clinical evaluation.
doi_str_mv	10.1007/BF00620476
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00620476</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77483670</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1296-5515d157988cd6e1445554f4c974278efc069b8c718f87fb9ac9ab564dc8b0b63</originalsourceid><addsrcrecordid>eNpFkM9LwzAcxYMoc04v3oWcPIjVb9r89DaHm8LEyzyXNE1HpM1q0jL231tZ0dM7vA8P3gehawIPBEA8Pi8BeApU8BM0JZyoRIBUp2gKGYWEKyXO0UWMXwBAacYmaJIqljLgU7RUqtmY5H2-yu6xxt7ucbBe19g1euv8Fuut9d0TboOtXeO8DocBiH3dRew8bnXnhj5eorNK19FejTlDn8uXzeI1WX-s3hbzdWJIqnjCGGElYUJJaUpuCaWMMVpRowRNhbSVAa4KaQSRlRRVobRRumCclkYWUPBshm6Pu23Yffc2dnnjorF1rb3d9TEXgsqMCxjAuyNowi7GYKu8DcOlcMgJ5L_S8n9pA3wzrvZFY8s_dLSU_QDR92Rk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77483670</pqid></control><display><type>article</type><title>99mTc-MAG3, a new renal imaging agent: preliminary results in patients</title><source>Alma/SFX Local Collection</source><creator>Taylor, Jr, A ; Eshima, D ; Alazraki, N</creator><creatorcontrib>Taylor, Jr, A ; Eshima, D ; Alazraki, N</creatorcontrib><description>99mTc-mercaptoacetyltriglycine (MAG3) is a new renal radiopharmaceutical which has been shown to have biological properties similar to 131I-hippurate (OIH) in animals and volunteers. 99mTc-MAG3 has now been compared with 131I-orthoiodohippurate (OIH) in a group of patients with varying degrees of renal impairment. In all cases, the 99mTc-MAG3 images were superior regardless of serum creatinine. Selected examples are illustrated including scans and renogram curves in a normal volunteer, transplant patients with creatinines of 9.8 mg/dl and 2.6 mg/dl respectively, and a furosemide study in a patient with questionable obstruction. Our preliminary results suggest that 99mTc-MAG3 performs well in patients with impaired renal function and may well provide an acceptable replacement for OIH. A kit formulation has been developed and will soon be undergoing clinical evaluation.</description><identifier>ISSN: 0340-6997</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/BF00620476</identifier><identifier>PMID: 2952506</identifier><language>eng</language><publisher>Germany</publisher><subject>Adult ; Female ; Humans ; Iodine Radioisotopes ; Iodohippuric Acid ; Kidney - diagnostic imaging ; Kidney - physiopathology ; Kidney Transplantation ; Oligopeptides ; Organometallic Compounds ; Radionuclide Imaging ; Technetium Tc 99m Mertiatide ; Ureteral Obstruction - diagnostic imaging</subject><ispartof>European Journal of Nuclear Medicine, 1987, Vol.12 (10), p.510-514</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1296-5515d157988cd6e1445554f4c974278efc069b8c718f87fb9ac9ab564dc8b0b63</citedby><cites>FETCH-LOGICAL-c1296-5515d157988cd6e1445554f4c974278efc069b8c718f87fb9ac9ab564dc8b0b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2952506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taylor, Jr, A</creatorcontrib><creatorcontrib>Eshima, D</creatorcontrib><creatorcontrib>Alazraki, N</creatorcontrib><title>99mTc-MAG3, a new renal imaging agent: preliminary results in patients</title><title>European Journal of Nuclear Medicine</title><addtitle>Eur J Nucl Med</addtitle><description>99mTc-mercaptoacetyltriglycine (MAG3) is a new renal radiopharmaceutical which has been shown to have biological properties similar to 131I-hippurate (OIH) in animals and volunteers. 99mTc-MAG3 has now been compared with 131I-orthoiodohippurate (OIH) in a group of patients with varying degrees of renal impairment. In all cases, the 99mTc-MAG3 images were superior regardless of serum creatinine. Selected examples are illustrated including scans and renogram curves in a normal volunteer, transplant patients with creatinines of 9.8 mg/dl and 2.6 mg/dl respectively, and a furosemide study in a patient with questionable obstruction. Our preliminary results suggest that 99mTc-MAG3 performs well in patients with impaired renal function and may well provide an acceptable replacement for OIH. A kit formulation has been developed and will soon be undergoing clinical evaluation.</description><subject>Adult</subject><subject>Female</subject><subject>Humans</subject><subject>Iodine Radioisotopes</subject><subject>Iodohippuric Acid</subject><subject>Kidney - diagnostic imaging</subject><subject>Kidney - physiopathology</subject><subject>Kidney Transplantation</subject><subject>Oligopeptides</subject><subject>Organometallic Compounds</subject><subject>Radionuclide Imaging</subject><subject>Technetium Tc 99m Mertiatide</subject><subject>Ureteral Obstruction - diagnostic imaging</subject><issn>0340-6997</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><recordid>eNpFkM9LwzAcxYMoc04v3oWcPIjVb9r89DaHm8LEyzyXNE1HpM1q0jL231tZ0dM7vA8P3gehawIPBEA8Pi8BeApU8BM0JZyoRIBUp2gKGYWEKyXO0UWMXwBAacYmaJIqljLgU7RUqtmY5H2-yu6xxt7ucbBe19g1euv8Fuut9d0TboOtXeO8DocBiH3dRew8bnXnhj5eorNK19FejTlDn8uXzeI1WX-s3hbzdWJIqnjCGGElYUJJaUpuCaWMMVpRowRNhbSVAa4KaQSRlRRVobRRumCclkYWUPBshm6Pu23Yffc2dnnjorF1rb3d9TEXgsqMCxjAuyNowi7GYKu8DcOlcMgJ5L_S8n9pA3wzrvZFY8s_dLSU_QDR92Rk</recordid><startdate>1987</startdate><enddate>1987</enddate><creator>Taylor, Jr, A</creator><creator>Eshima, D</creator><creator>Alazraki, N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1987</creationdate><title>99mTc-MAG3, a new renal imaging agent: preliminary results in patients</title><author>Taylor, Jr, A ; Eshima, D ; Alazraki, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1296-5515d157988cd6e1445554f4c974278efc069b8c718f87fb9ac9ab564dc8b0b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Female</topic><topic>Humans</topic><topic>Iodine Radioisotopes</topic><topic>Iodohippuric Acid</topic><topic>Kidney - diagnostic imaging</topic><topic>Kidney - physiopathology</topic><topic>Kidney Transplantation</topic><topic>Oligopeptides</topic><topic>Organometallic Compounds</topic><topic>Radionuclide Imaging</topic><topic>Technetium Tc 99m Mertiatide</topic><topic>Ureteral Obstruction - diagnostic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taylor, Jr, A</creatorcontrib><creatorcontrib>Eshima, D</creatorcontrib><creatorcontrib>Alazraki, N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European Journal of Nuclear Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taylor, Jr, A</au><au>Eshima, D</au><au>Alazraki, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>99mTc-MAG3, a new renal imaging agent: preliminary results in patients</atitle><jtitle>European Journal of Nuclear Medicine</jtitle><addtitle>Eur J Nucl Med</addtitle><date>1987</date><risdate>1987</risdate><volume>12</volume><issue>10</issue><spage>510</spage><epage>514</epage><pages>510-514</pages><issn>0340-6997</issn><eissn>1619-7089</eissn><abstract>99mTc-mercaptoacetyltriglycine (MAG3) is a new renal radiopharmaceutical which has been shown to have biological properties similar to 131I-hippurate (OIH) in animals and volunteers. 99mTc-MAG3 has now been compared with 131I-orthoiodohippurate (OIH) in a group of patients with varying degrees of renal impairment. In all cases, the 99mTc-MAG3 images were superior regardless of serum creatinine. Selected examples are illustrated including scans and renogram curves in a normal volunteer, transplant patients with creatinines of 9.8 mg/dl and 2.6 mg/dl respectively, and a furosemide study in a patient with questionable obstruction. Our preliminary results suggest that 99mTc-MAG3 performs well in patients with impaired renal function and may well provide an acceptable replacement for OIH. A kit formulation has been developed and will soon be undergoing clinical evaluation.</abstract><cop>Germany</cop><pmid>2952506</pmid><doi>10.1007/BF00620476</doi><tpages>5</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0340-6997
ispartof	European Journal of Nuclear Medicine, 1987, Vol.12 (10), p.510-514
issn	0340-6997 1619-7089
language	eng
recordid	cdi_crossref_primary_10_1007_BF00620476
source	Alma/SFX Local Collection
subjects	Adult Female Humans Iodine Radioisotopes Iodohippuric Acid Kidney - diagnostic imaging Kidney - physiopathology Kidney Transplantation Oligopeptides Organometallic Compounds Radionuclide Imaging Technetium Tc 99m Mertiatide Ureteral Obstruction - diagnostic imaging
title	99mTc-MAG3, a new renal imaging agent: preliminary results in patients
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A27%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=99mTc-MAG3,%20a%20new%20renal%20imaging%20agent:%20preliminary%20results%20in%20patients&rft.jtitle=European%20Journal%20of%20Nuclear%20Medicine&rft.au=Taylor,%20Jr,%20A&rft.date=1987&rft.volume=12&rft.issue=10&rft.spage=510&rft.epage=514&rft.pages=510-514&rft.issn=0340-6997&rft.eissn=1619-7089&rft_id=info:doi/10.1007/BF00620476&rft_dat=%3Cproquest_cross%3E77483670%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1296-5515d157988cd6e1445554f4c974278efc069b8c718f87fb9ac9ab564dc8b0b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77483670&rft_id=info:pmid/2952506&rfr_iscdi=true